Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, July 15, 2026, 1:00-2:00 PM ET
Hear an expert discuss how to integrate Kappa and Lambda in situ hybridization testing into your standard hematopathology workflow to accurately assess B-cell and plasma cell clonality. You will also gain the skills to recognize testing pitfalls in challenging reactive versus neoplastic proliferations and apply ancillary tools to resolve complex cases.
Webinar presenter Xiaojun Wu, MD, PhD, Assistant professor, Director of Hematopathology Section at NCR of Johns Hopkins Medicine Department of Pathology, SOM at Johns Hopkins University
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
A review paper released by cancer diagnostics firm Dako aims to provide prostate pathologists a comprehensive reference on the use of various prostate markers, as well as their limitations. Download the paper.
Keith J. Kaplan, MD, discusses his lab’s experience with the Sakura VisionTek Digital Microscope. At the Digital Pathology Blog, Dr. Kaplan calls the system “a must-see for real-time applications with point-to-point case sharing.” Read more.
In this HIStalk interview, Partners HealthCare pathology project director Lyman Garniss addresses the challenge laboratories face in managing genomic information, how EMR systems still fall short when compared with LIS, and the promise of biorepositories.
Viewics Inc., which makes software designed to help clinical and anatomic pathology laboratories with their dashboarding and data-mining needs, is offering a free demonstration on Thursday, Jan. 23. The demo aims to showcase how the company’s product can help track revenue and volume, analyze per-test costs and supply expenses, identify TAT outliers, and scrutinize workload, staffing, and QA/QC issues.Register.
Read how a patient risk approach to QC means planning your QC based on the type or method of the test and its impact on patient outcomes when a failure is detected.
Validating Whole Slide Imaging for Diagnostic Purposes in Pathology: This guideline, available in Archives of Pathology & Laboratory Medicine, marks a significant step in demonstrating the value of this emerging technology for diagnostic use.
Executives at Carmel, Ind.-based laboratory information system company Orchard Software share their views on how health care’s change from a volume-based to a value-based service model will affect the lab. This presentation points out specific ways that the laboratory can deliver for its facility and its customers in a value-based reimbursement world. Watch the video.
Digital Pathology Association Webinar, The use of digital pathology technology in research environment, features Robert W. Dunstan and Christopher D. Higgins.
GenMark offers on Tuesday, Sept. 17 for a free webinar on multiplex respiratory virus testing. As part of the webinar, Benjamin Pinsky, MD, PhD, Stanford University, will discuss the transition from traditional culture and direct antigen testing to molecular diagnostics. P.A.C.E. credit available. Register here.
AdvaMedDx’s free executive newsletter for August 2013 is now available. Covered in the newsletter is information about a diagnostics payment reform bill, FDA news on companion diagnostic tests, and views from the company’s director Andrew C. Fish. [Download here] * More CAP TODAY Recommends * *
